Ensifentrine
Ensifentrine, sold under the brand name Ohtuvayre, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD) in adults.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Ensifentrine, sold under the brand name Ohtuvayre, is a medication used for the treatment of chronic obstructive pulmonary disease (COPD) in adults. It is a phosphodiesterase 3 inhibitor and phosphodiesterase 4 inhibitor. It is given by inhalation.
PDE3 inhibitors act as bronchodilators, while PDE4 inhibitors have an anti-inflammatory effect. Ensifentrine was approved for medical use in the United States in June 2024.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1369634565 under CC BY-SA 4.0; modifications have been made.